INS and type 2 diabetes mellitus: In the present review we provide an overview of the weekly insulin analogues that are currently being studied for the treatment of both type 1 and type 2 diabetes, focusing on the two molecules that are furthest along the clinical experimental programme: insulin icodec and basal insulin Fc (BIF; insulin efsitora alfa).